Literature DB >> 29256882

A Mexican Standoff: Mitral stenosis, mitral balloon valvuloplasty, Tp-e interval, Tp-e/QT and Tp-e/QTc ratios and sympathetic activity.

Uğur Nadir Karakulak1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29256882      PMCID: PMC6282896          DOI: 10.14744/AnatolJCardiol.2017.8062

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, I have read with great interest the study entitled, “Evaluation of Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Mitral Valve Stenosis Before and After Balloon Valvuloplasty” (1). The authors demonstrated that Tp-e interval and Tp-e/QT and Tp-e/QTc ratios were prolonged in patients with mitral stenosis compared with healthy subjects and these parameters were favorably affected by percutaneous mitral balloon valvuloplasty (PMBV) even 24 h after the procedure. In addition, they affirmed that the link between ventricular repolarization abnormality, mitral stenosis, and effects of PMBV was sympathetic activation. Improvement seen in these arrhythmic markers in such short time and limited number of patients is striking and may be debatable. Similar to the present study, Özdemir et al. (2) showed that heart rate variability indices improved 1 day after PBMV. However, in another study, Ashino et al. (3) showed a reduction in sympathetic activity measured by muscle sympathetic activity in patients with mitral stenosis at 1 week after PBMV. Similarly, Yuasa et al. (4) demonstrated that muscle sympathetic nerve activity attenuated and cardiopulmonary baroreflex sensitivity improved 1 week after PBMV in patients with mitral stenosis. In the studies in which sympathetic activity is evaluated 1 week after PMBV, significant changes in electrocardiographic parameters just 1 day after PMBV seem to be too early. I believe that it would be more accurate and valuable if a sympathetic activity marker is measured and analyzed to determine significant correlations with electro- and echocardiographic parameters before and after the procedure. In conclusion, this study can be a source of inspiration for further research in patients with aortic stenosis treated with transcatheter aortic valve implantation and hypertrophic cardiomyopathy treated with septal ablation because of similar mechanisms.
  4 in total

1.  Percutaneous transluminal mitral valvuloplasty normalizes baroreflex sensitivity and sympathetic activity in patients with mitral stenosis.

Authors:  K Ashino; E Gotoh; S Sumita; A Moriya; M Ishii
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

2.  Percutaneous transluminal mitral valvuloplasty improves cardiopulmonary baroreflex sensitivity in patients with mitral stenosis.

Authors:  T Yuasa; S Takata; T Terasaki; M Kontani; S Saito; H Nagai; A Shimakura; S Sakagami; K Kobayashi
Journal:  Auton Neurosci       Date:  2001-12-10       Impact factor: 3.145

3.  Improvement in sympatho-vagal imbalance and heart rate variability in patients with mitral stenosis after percutaneous balloon commissurotomy.

Authors:  Ozcan Ozdemir; Omer Alyan; Mustafa Soylu; Fatma Metin; Fehmi Kacmaz; Ahmet Duran Demir; Bilal Geyik; Dursun Aras; Hatice Sasmaz; Sule Korkmaz
Journal:  Europace       Date:  2005-05       Impact factor: 5.214

4.  Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with mitral valve stenosis before and after balloon valvuloplasty.

Authors:  Muhammet Dural; Kadir Uğur Mert; Kemal İskenderov
Journal:  Anatol J Cardiol       Date:  2017-10-13       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.